Masimo (NASDAQ: MASI) announced today FDA 510(k) clearance for the TFA-1™ Single-Patient-Use Adhesive Forehead Sensor. This single-patient-use sensor allows clinicians to monitor patients using Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry from an alternative monitoring site, the forehead, rather than a finger. Forehead sensors may provide oxygen saturation measurements that are less susceptible Read more about Single-patient-use sensor allows clinicians to monitor patients[…]